Incretin hormone agonists as promising antiobesity drugs - review of literature
The aim of this work is to draw attention to the recently growing problem of obesity and complications related to it. Dietary recommendations and recommendations regarding physical activity turned out not to show satisfactory effects in patients with obesity in terms of weight loss, but also in mai...
Saved in:
Main Authors: | Aleksandra Grzegorczyk, Justyna Korus, Marta Dziedziak, Nicol Dardzińska, Natalia Hopej |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2025-01-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/56677 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01) -
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
by: Jonathan D. Douros, et al.
Published: (2025-02-01) -
The protective role of GLP-1 in neuro-ophthalmology
by: Sohum Sheth, et al.
Published: (2023-08-01) -
One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists
by: Hirotaka Watada
Published: (2025-02-01) -
Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
by: Michelle Wei, et al.
Published: (2025-01-01)